CLDX
Celldex Therapeutics Inc.
$25.17
+$0.51(+2.07%)
48
Overall
60
Value
36
Tech
50
Quality
Market Cap
$1.79B
Volume
809.22K
52W Range
$14.40 - $30.50
Target Price
$53.36
Key Metrics Overview
| Market Cap | $1.79B | P/E Ratio | N/A |
| 52W High | $30.50 | 52W Low | $14.40 |
| Div Yield | N/A | Payout Ratio | N/A |
| EPS Growth 3Y | -14.3% | 52W Position | 66.9% |
| Overall Score | 48 | Value Score | 60 |
| Quality Score | 50 | Technical Score | 36 |
Growth Analysis
| EPS Current Est | $-3.63 | EPS Next Est | $-4.59 |
| EPS Growth Est | N/A | DPS Growth 3Y | N/A |
Revenue (5Y)
EBITDA (5Y)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | CLDX | $25.17 | +2.1% | 809.22K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Celldex Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW